| Income Statement |
| Total Revenue | 15.92M |
|
| Revenues (USD) | 15.92M |
| Cost of Revenue | 2.82M |
| Gross Profit | 13.10M |
| Operating Expenses | 12.83M |
| Research and Development Expense | 3.07M |
| Selling, General and Administrative Expense | 8.61M |
| Operating Income | 266.00K |
| Income Tax Expense | 1.94M |
| Net Income | -20.05M |
| Net Income Common Stock | -20.05M |
| Net Income Common Stock (USD) | -20.05M |
| Consolidated Income | -20.05M |
| Earnings per Basic Share | -0.13 |
| Earnings per Basic Share (USD) | -0.13 |
| Earnings per Diluted Share | -0.13 |
| Earning Before Interest & Taxes (EBIT) | -18.11M |
| Earning Before Interest & Taxes (USD) | -18.11M |
| Weighted Average Shares | 150.59M |
| Weighted Average Shares Diluted | 150.59M |
| Balance Sheet |
| Cash and Equivalents | 121.93M |
| Cash and Equivalents (USD) | 121.93M |
| Investments | 14.95M |
| Investments Non-Current | 14.95M |
| Trade and Non-Trade Receivables | 9.52M |
| Current Assets | 139.59M |
| Property, Plant & Equipment Net | 40.15M |
| Total Assets | 196.25M |
| Debt Current | 1.27M |
| Total Debt | 96.49M |
| Current Liabilities | 59.75M |
| Debt Non-Current | 95.22M |
| Total Liabilities | 162.37M |
| Accumulated Retained Earnings (Deficit) | -543.24M |
| Accumulated Other Comprehensive Income | -267.00K |
| Shareholders Equity | 33.88M |
| Shareholders Equity (USD) | 33.88M |
| Assets Non-Current | 56.66M |
| Total Debt (USD) | 96.49M |
| Deferred Revenue | 18.10M |
| Inventory | 1.82M |
| Liabilities Non-Current | 102.61M |
| Trade and Non-Trade Payables | 4.43M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.64M |
| Net Cash Flow from Financing | -164.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.09M |
| Capital Expenditure | 2.70M |
| Issuance (Purchase) of Equity Shares | 224.00K |
| Net Cash Flow from Investing | 2.70M |
| Net Cash Flow from Operations | -8.63M |
| Effect of Exchange Rate Changes on Cash | 34.00K |
| Share Based Compensation | 1.43M |